Previous reports have described the association of EPPK1 with poor prognosis in hepatocellular cancer and esophageal squamous cell cancer [26, 27], as well as its potential as a biomarker for pancreatic and cervical cancer [28, 29]. This evidence concerns the gene EPPK1 and cervical cancer.